 Patrick Hume
Concepts (147)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cigarette Smoking | 2 | 2022 | 102 | 1.210 |
Why?
| | Lung | 10 | 2026 | 4116 | 0.900 |
Why?
| | Macrophages, Alveolar | 3 | 2024 | 373 | 0.710 |
Why?
| | Pressure | 1 | 2021 | 226 | 0.620 |
Why?
| | Pulmonary Emphysema | 1 | 2022 | 277 | 0.600 |
Why?
| | Blood Vessels | 1 | 2021 | 167 | 0.590 |
Why?
| | Perfusion | 1 | 2021 | 251 | 0.590 |
Why?
| | Pulmonary Alveoli | 1 | 2021 | 387 | 0.540 |
Why?
| | Polyethylene Glycols | 3 | 2012 | 649 | 0.540 |
Why?
| | Patient Care Planning | 1 | 2018 | 170 | 0.500 |
Why?
| | Hydrogels | 4 | 2023 | 701 | 0.490 |
Why?
| | Shock, Septic | 1 | 2018 | 227 | 0.470 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 920 | 0.430 |
Why?
| | Hospital Mortality | 1 | 2018 | 1038 | 0.390 |
Why?
| | Metalloporphyrins | 1 | 2011 | 63 | 0.330 |
Why?
| | Coated Materials, Biocompatible | 1 | 2011 | 65 | 0.330 |
Why?
| | Superoxides | 1 | 2011 | 198 | 0.320 |
Why?
| | Biomimetic Materials | 1 | 2011 | 78 | 0.320 |
Why?
| | fas Receptor | 1 | 2010 | 91 | 0.310 |
Why?
| | Mice | 13 | 2025 | 18358 | 0.300 |
Why?
| | Photochemistry | 1 | 2010 | 127 | 0.300 |
Why?
| | Polymers | 2 | 2011 | 485 | 0.300 |
Why?
| | Superoxide Dismutase | 1 | 2011 | 308 | 0.290 |
Why?
| | Dendritic Cells | 1 | 2012 | 501 | 0.270 |
Why?
| | T-Lymphocytes | 3 | 2012 | 1998 | 0.270 |
Why?
| | Biocompatible Materials | 1 | 2012 | 429 | 0.260 |
Why?
| | Leukocytes | 3 | 2026 | 296 | 0.260 |
Why?
| | Animals | 14 | 2025 | 38106 | 0.220 |
Why?
| | Toll-Like Receptors | 1 | 2026 | 193 | 0.220 |
Why?
| | Fucosyltransferases | 1 | 2025 | 33 | 0.220 |
Why?
| | Apoptosis | 2 | 2011 | 2445 | 0.210 |
Why?
| | Chemokine CXCL12 | 1 | 2025 | 86 | 0.210 |
Why?
| | Bronchial Hyperreactivity | 1 | 2025 | 104 | 0.210 |
Why?
| | Mucus | 1 | 2025 | 75 | 0.210 |
Why?
| | Bioengineering | 1 | 2024 | 20 | 0.210 |
Why?
| | Orthomyxoviridae Infections | 1 | 2024 | 71 | 0.200 |
Why?
| | Alternative Splicing | 1 | 2026 | 248 | 0.200 |
Why?
| | Vascular System Injuries | 1 | 2023 | 81 | 0.180 |
Why?
| | X-Ray Microtomography | 1 | 2022 | 108 | 0.180 |
Why?
| | Precancerous Conditions | 1 | 2023 | 166 | 0.180 |
Why?
| | Calcitonin Gene-Related Peptide | 1 | 2022 | 40 | 0.180 |
Why?
| | Neuropeptides | 1 | 2022 | 75 | 0.170 |
Why?
| | Vaping | 1 | 2023 | 74 | 0.170 |
Why?
| | Ventilator-Induced Lung Injury | 1 | 2022 | 61 | 0.170 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2023 | 110 | 0.170 |
Why?
| | Repressor Proteins | 1 | 2024 | 429 | 0.170 |
Why?
| | Fixatives | 1 | 2021 | 13 | 0.170 |
Why?
| | Leukosialin | 1 | 2020 | 12 | 0.160 |
Why?
| | Mannose-Binding Lectins | 1 | 2020 | 10 | 0.160 |
Why?
| | Optical Devices | 1 | 2020 | 13 | 0.160 |
Why?
| | Mice, Inbred C57BL | 4 | 2025 | 5995 | 0.160 |
Why?
| | Immunoglobulin G | 1 | 2024 | 892 | 0.160 |
Why?
| | Lectins, C-Type | 1 | 2020 | 59 | 0.160 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2022 | 298 | 0.160 |
Why?
| | Medical Writing | 1 | 2019 | 2 | 0.150 |
Why?
| | Killer Cells, Natural | 1 | 2023 | 481 | 0.150 |
Why?
| | Lung Injury | 1 | 2023 | 249 | 0.150 |
Why?
| | Cell Count | 1 | 2020 | 319 | 0.150 |
Why?
| | Neutrophils | 1 | 2025 | 1127 | 0.140 |
Why?
| | Pneumonia | 1 | 2024 | 636 | 0.140 |
Why?
| | Influenza, Human | 1 | 2024 | 624 | 0.140 |
Why?
| | Disease Models, Animal | 3 | 2025 | 4568 | 0.140 |
Why?
| | Boston | 1 | 2018 | 93 | 0.140 |
Why?
| | RNA, Messenger | 1 | 2026 | 2805 | 0.140 |
Why?
| | Receptors, Cell Surface | 1 | 2020 | 372 | 0.130 |
Why?
| | Lung Diseases | 1 | 2024 | 782 | 0.130 |
Why?
| | Mice, Transgenic | 1 | 2022 | 2192 | 0.130 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2023 | 923 | 0.120 |
Why?
| | Tissue Donors | 1 | 2020 | 420 | 0.120 |
Why?
| | Humans | 17 | 2026 | 145785 | 0.120 |
Why?
| | Immunohistochemistry | 1 | 2020 | 1723 | 0.120 |
Why?
| | Linear Models | 1 | 2018 | 849 | 0.120 |
Why?
| | Fellowships and Scholarships | 1 | 2019 | 354 | 0.110 |
Why?
| | Disease Management | 1 | 2018 | 653 | 0.100 |
Why?
| | Macrophages | 1 | 2022 | 1507 | 0.100 |
Why?
| | Flow Cytometry | 2 | 2022 | 1165 | 0.100 |
Why?
| | Research Design | 1 | 2019 | 1139 | 0.100 |
Why?
| | Asthma | 1 | 2025 | 1797 | 0.100 |
Why?
| | Biomedical Research | 1 | 2019 | 719 | 0.090 |
Why?
| | Case-Control Studies | 1 | 2020 | 3634 | 0.090 |
Why?
| | Glucose Oxidase | 1 | 2011 | 25 | 0.090 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2026 | 638 | 0.090 |
Why?
| | Coculture Techniques | 1 | 2012 | 247 | 0.080 |
Why?
| | 3T3 Cells | 1 | 2011 | 156 | 0.080 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2012 | 177 | 0.080 |
Why?
| | Materials Testing | 1 | 2012 | 345 | 0.080 |
Why?
| | Lung Neoplasms | 1 | 2023 | 2668 | 0.080 |
Why?
| | Jurkat Cells | 1 | 2010 | 115 | 0.080 |
Why?
| | Mice, Inbred NOD | 1 | 2012 | 616 | 0.080 |
Why?
| | Interleukin-10 | 1 | 2012 | 311 | 0.080 |
Why?
| | Middle Aged | 3 | 2026 | 36309 | 0.070 |
Why?
| | Cell Adhesion | 1 | 2010 | 451 | 0.070 |
Why?
| | Lymphocyte Activation | 1 | 2012 | 1133 | 0.070 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 849 | 0.070 |
Why?
| | Mice, Knockout | 2 | 2025 | 3130 | 0.070 |
Why?
| | Female | 5 | 2026 | 79045 | 0.060 |
Why?
| | Endothelial Cells | 2 | 2025 | 878 | 0.060 |
Why?
| | Immunosuppressive Agents | 1 | 2012 | 838 | 0.060 |
Why?
| | Male | 4 | 2026 | 73012 | 0.060 |
Why?
| | Genetic Enhancement | 1 | 2006 | 5 | 0.060 |
Why?
| | DNA Probes | 1 | 2006 | 59 | 0.060 |
Why?
| | Interleukin-1 Receptor-Associated Kinases | 1 | 2026 | 41 | 0.060 |
Why?
| | Signal Transduction | 2 | 2026 | 5226 | 0.060 |
Why?
| | Cell Line | 1 | 2011 | 2823 | 0.060 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2026 | 119 | 0.060 |
Why?
| | Protein Engineering | 1 | 2006 | 122 | 0.050 |
Why?
| | Mucin 5AC | 1 | 2025 | 71 | 0.050 |
Why?
| | Glycosylation | 1 | 2025 | 173 | 0.050 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2006 | 751 | 0.050 |
Why?
| | Cell Differentiation | 1 | 2012 | 2050 | 0.050 |
Why?
| | Escherichia coli Proteins | 1 | 2006 | 201 | 0.050 |
Why?
| | Urethane | 1 | 2023 | 43 | 0.050 |
Why?
| | Cells, Cultured | 1 | 2011 | 4151 | 0.050 |
Why?
| | Cell- and Tissue-Based Therapy | 1 | 2024 | 78 | 0.050 |
Why?
| | Stem Cell Transplantation | 1 | 2024 | 189 | 0.050 |
Why?
| | Immunoglobulins | 1 | 2023 | 163 | 0.050 |
Why?
| | Mucin-5B | 1 | 2025 | 234 | 0.050 |
Why?
| | Receptors, KIR | 1 | 2023 | 118 | 0.050 |
Why?
| | Ceramides | 1 | 2023 | 117 | 0.050 |
Why?
| | Thymus Gland | 1 | 2023 | 312 | 0.040 |
Why?
| | Regeneration | 1 | 2024 | 198 | 0.040 |
Why?
| | Tidal Volume | 1 | 2022 | 109 | 0.040 |
Why?
| | Escherichia coli | 1 | 2006 | 835 | 0.040 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2023 | 334 | 0.040 |
Why?
| | Positive-Pressure Respiration | 1 | 2022 | 115 | 0.040 |
Why?
| | Ligands | 1 | 2023 | 668 | 0.040 |
Why?
| | NF-kappa B | 1 | 2024 | 667 | 0.040 |
Why?
| | Adolescent | 1 | 2020 | 22577 | 0.040 |
Why?
| | Time Factors | 1 | 2011 | 7134 | 0.040 |
Why?
| | Dronabinol | 1 | 2023 | 249 | 0.040 |
Why?
| | Tissue Engineering | 1 | 2024 | 438 | 0.040 |
Why?
| | Aged | 1 | 2020 | 26217 | 0.040 |
Why?
| | Financing, Organized | 1 | 2019 | 36 | 0.040 |
Why?
| | Stem Cells | 1 | 2024 | 630 | 0.040 |
Why?
| | Teaching | 1 | 2019 | 237 | 0.030 |
Why?
| | Respiration, Artificial | 1 | 2022 | 714 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2025 | 2933 | 0.030 |
Why?
| | Adult | 1 | 2020 | 40882 | 0.030 |
Why?
| | Hypoxia | 1 | 2022 | 1199 | 0.030 |
Why?
| | Drug Tolerance | 1 | 2006 | 99 | 0.010 |
Why?
| | Heat-Shock Response | 1 | 2006 | 77 | 0.010 |
Why?
| | United States | 1 | 2023 | 16126 | 0.010 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2006 | 376 | 0.010 |
Why?
| | DNA, Bacterial | 1 | 2006 | 320 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2006 | 1368 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2006 | 3418 | 0.010 |
Why?
| | Mutation | 1 | 2006 | 4090 | 0.010 |
Why?
|
|
Hume's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|